RV 156A

A phase I clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 recombinant Adenovirus-5 vector vaccine, VRC-HIV ADV014-00-VP administered alone or administered as a boost to a multiclade HIV-1 DNA Plasmid vaccine, VRC-HIVDNA009-00-VP, in uninfected adult volunteers in Uganda.

Trial Details:

I Completed
VRC, Makerere University Walter Reed Project April 30, 2007
VRC-HIVDNA009-00-VP,VRC-HIVADV014-00-VP DNA gag B, gol B, nef B, env A, env B, env C ; Ad5 Gag-Pol Env A/B/C
VRC-HIVADV014-00-VP Viral Vector - Adeno
Uganda 29